Finally, your rapporteur has sought to avoid giving manufacturers of generic pharmaceuticals under compulsory licences an unfair competitive advantage.
Finally, your rapporteur has sought to avoid giving manufacturers of generic pharmaceuticals under compulsory licences an unfair competitive advantage.